EPB0190 eGFR change after transitioning to DTG-based ART at Newlands Clinic in Zimbabwe: a cohort studyE-posterClinical complications of HIV and antiretroviral therapy
EPB0191 Blood pressure among people living with HIV transitioning from efavirenz- to dolutegravir-based ART: a cohort study from ZimbabweE-posterClinical complications of HIV and antiretroviral therapy
EPB0192 96-week update: change in weight and BMI associated with switching to bictegravir/emtricitabine/tenofovir alafenamide vs. a dolutegravir-based regimen among virologically suppressed adults living with HIVE-posterClinical complications of HIV and antiretroviral therapy
EPB0193 CD4+ T lymphocyte recovery and cognitive function in women living with HIVE-posterClinical complications of HIV and antiretroviral therapy
EPB0194 Improving the safety of clients on antiretroviral therapy through Drug Use Evaluations (DUE) to manage adverse drug events at six ART sites in the Oromia region of EthiopiaE-posterClinical complications of HIV and antiretroviral therapy
EPB0195 Impact of GLP-1 receptor agonists on body weight in patients with type 2 diabetes and HIVE-posterClinical complications of HIV and antiretroviral therapy
EPB0196 Thymosin α1 in restoring immune response in immunological nonrespondersE-posterClinical complications of HIV and antiretroviral therapy
EPB0197 Metabolic syndrome among persons living with HIV on DTG based antiretroviral regimen: outcomes from a longitudinal cohort study in GhanaE-posterClinical complications of HIV and antiretroviral therapy
EPB0198 A patient with undiagnosed HIV presenting with hemophagocytic lymphohistiocytosis - the importance of routine HIV testing in hospitalized patientsE-posterClinical complications of HIV and antiretroviral therapy
EPB0199 Weight gain and lipid changes with switching from boosted protease inhibitor-based regimens to bictegravir/tenofovir alafenamide/emtricitabineE-posterClinical complications of HIV and antiretroviral therapy
311 - 320 of 1427 items